RecruitingNCT04988685

SIROOP Registry - A Prospective Registry Study to Evaluate the Outcomes of Coronary Artery Disease Patients Treated With SIROlimus Or Paclitaxel Eluting Balloon Catheters

Sponsor

Luzerner Kantonsspital

Enrollment

2,000 participants

Start Date

Jun 1, 2021

Study Type

OBSERVATIONAL

Conditions

Coronary Restenosis Coronary Disease Coronary Artery Disease Coronary Arteriosclerosis Coronary Artery Calcification Angina Pectoris Angina, Stable Stent Thrombosis Angina, Unstable Stable Chronic Angina

Summary

The purpose of the SIROOP Registry is to retrospectively and prospectively collect baseline, clinical and procedural characteristics of patients who have undergone PCI and are treated with either currently available sirolimus or paclitaxel coated DCBs (see Table 1), irrespective of clinical presentation as well as to prospectively collect data about their clinical outcomes. Outcomes will be compared in different clinical subgroups. The impact of current DCBs in different clinical settings and coronary artery lesions on cardiovascular outcomes will be assessed.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Sirolimus Eluting Balloon for people with angina pectoris, angina, stable, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.